Implementation of a SARS-CoV-2 genomic surveillance network as a strategy to face other health challenges in Peru
DOI:
https://doi.org/10.17843/rpmesp.2026.431.15048Keywords:
Public Health Surveillance, SARS-CoV-2, High-Throughput Nucleotide Sequencing, COVID-19Abstract
We present a complete description of the implementation of SARS-CoV-2 genomic surveillance during the COVID-19 pandemic in Peru, and the impact of applying this technology to other pathogens important for the country’s public health. This aims to highlight the achievements, challenges, and lessons learned that allow for strengthening the response to current and future health challenges at the national level, as well as public health decisions. With the genomic surveillance initiative led by the National Institute of Health, 48,691 SARS-CoV-2 genomes from all regions of the country have been sequenced from 2020 to 2024, achieving the identification of eight variants of the virus and the designation of 25 new lineages within the Gamma, Delta, and Omicron variants. Genomic surveillance of SARS-CoV-2 has allowed for the timely identification of variants of epidemiological interest, monitoring the evolution of the virus in real-time, and using this information as a tool for public health decision-making. This experience subsequently provided the basis for monitoring other pathogens that have caused health emergencies in Peru and the world, such as dengue, influenza, and mpox.
Downloads
References
World Health Organization. Global genomic surveillance strategy for pathogens with pandemic and epidemic potential 2022-2032: Progress report on the first year of implementation. Geneva: World Health Organization; 2023.
Ferdinand AS, Kelaher M, Lane CR, Gonçalves da Silva A, Sherry NL, Ballard SA, et al. An implementation science approach to evaluating pathogen whole genome sequencing in public health. Genome Med. 2021;13(1):121. doi: 10.1186/s13073-021-00934-7.
Mantari Torpoco CR, Berrocal Huallpa AM, Espinoza-Culupú AO, López-Ingunza RL. Caracterización molecular de la nucleoproteína del virus de la rabia en canes procedentes de Arequipa, Perú. Rev Peru Med Exp Salud Publica. 2019;36(1):46–53. doi: 10.17843/RPMESP.2019.361.3938.
Condori-Yujra FJ, Jimenez-Vasquez VA, Enríquez-Alva GW, Cabezudo-Pillpe NE. Caracterización genética del virus de varicela zoster aislado de casos clínicos complicados en Perú en 2016 y 2017. Rev Peru Med Exp Salud Publica. 2018;35(3):533–4. doi: 10.17843/RPMESP.2018.353.3706.
Palacios-Salvatierra R, Huaringa-Núñez M, Lope-Pari P, Balbuena-Torres J, Rojas-Serrano N. Plataforma laboratorial para monitorear el SARS-CoV-2 basada en la vigilancia de influenza y otros virus respiratorios en Perú. Rev Peru Med Exp Salud Publica. 2022;39(1):104–10. doi: 10.17843/RPMESP.2022.391.8380.
Padilla-Rojas C, Lope-Pari P, Vega-Chozo K, Balbuena-Torres J, Caceres-Rey O, Bailon-Calderon H, et al. Near-Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Peru. Microbiol Resour Announc. 2020;9(19). doi: 10.1128/MRA.00303-20.
Molina-Mora JA, Reales-González J, Camacho E, Duarte-Martínez F, Tsukayama P, Soto-Garita C, et al. Overview of the SARS-CoV-2 enotypes circulating in Latin America during 2021. Front Public Health. 2023;11. doi: 10.3389/FPUBH.2023.1095202.
Concha-Toloza M, Collado González L, Herrera Estrella AH, Fernandez Do Porto D, Campos-Sánchez R, Molina-Mora JA, et al. Genomic, socio-environmental, and sequencing capability patterns in the surveillance of SARS-CoV-2 in Latin America and the Caribbean up to 2023. Research Square [Preprint] 2024. doi: 10.21203/RS.3.RS-5321558/V1.
Saavedra-Camacho JL, Iglesias-Osores S, Alcántara-Mimbela M, Córdova-Rojas LM. Análisis de genomas de SARS-COV-2 en muestras de Perú Facultad de Medicina Humana URP. Rev Fac Med Hum. 2021;21(3):475–85. doi: 10.25176/RFMH.v21i3.3712.
Padilla-Rojas C, Barcena-Flores L, Vega-Chozo K, Galarza-Perez M, Bailon-Calderon H, Lope-Pari P, et al. Near-Complete Genome Sequence of a SARS-CoV-2 VOC 202012/01 Strain in Peru. Microbiol Resour Announc. 2021;10(12). doi: 10.1128/MRA.00069-21.
Padilla-Rojas C, Jimenez-Vasquez V, Hurtado V, Mestanza O, Molina IS, Barcena L, et al. Genomic analysis reveals a rapid spread and predominance of lambda (C.37) SARS‐COV‐2 lineage in Peru despite circulation of variants of concern. J Med Virol. 2021;93(12):6845. doi: 10.1002/JMV.27261.
Vargas-Herrera N, Araujo-Castillo RV, Mestanza O, Galarza M, Rojas-Serrano N, Solari-Zerpa L. SARS-CoV-2 Lambda and Gamma variants competition in Peru, a country with high seroprevalence. Lancet Reg Health Am. 2022:6:100112. doi: 10.1016/j.lana.2021.100112.
Qu P, Evans JP, Faraone J, Zheng Y-M, Carlin C, Anghelina M, et al. Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2. bioRxiv. 2022;2022.10.19.512891. doi: 10.1101/2022.10.19.512891.
Jimenez-Vasquez V, Vargas-Herrera N, Bárcena-Flores L, Hurtado V, Padilla-Rojas C, Araujo-Castillo R V. Dispersion of SARS-CoV-2 lineage BA.5.1.25 and its descendants in Peru during two COVID-19 waves in 2022. Genomics Inform. 2024;22(1):1–6. doi: 10.1186/S44342-024-00006-3/TABLES/1.
Ito J, Suzuki R, Uriu K, Itakura Y, Zahradnik J, Kimura KT, et al. Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant. Nat Commun. 2023;14(1). doi: 10.1038/S41467-023-38188-Z.
Tegally H, Moir M, Everatt J, Giovanetti M, Scheepers C, Wilkinson E, et al. Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa. Nat Med. 2022;28(9):1785–90. doi: 10.1038/s41591-022-01911-2.
Molina IS, Jimenez-Vasquez V, Lizarraga W, Sevilla N, Hurtado V, Padilla-Rojas C. Sub-lineage B.1.6 of hMPXV in a global context: Phylogeny and epidemiology. J Med Virol. 2023;95(9):e29056. doi: 10.1002/JMV.29056.
Sevilla N, Lizarraga W, Jimenez-Vasquez V, Hurtado V, Molina IS, Huarca L, et al. Highly pathogenic avian influenza A (H5N1) virus outbreak in Peru in 2022–2023. Infect Med. 2024;3(2):100108. doi: 10.1016/J.IMJ.2024.100108.
Bailon H, Jimenez V, Galarza M, Medrano P, Mestanza O, Figueroa D, et al. Rapid spread of the emerging cosmopolitan genotype of dengue virus serotype 2, and expansion of dengue virus serotype 1 genotype V in Peru. Rev Peru Med Exp Salud Publica. 2024;41(4):375–84. doi: 10.17843/RPMESP.2024.414.13898.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Carlos Padilla‐Rojas, Verónica Hurtado, Wendy Lizarraga, Víctor Jimenez‐Vasquez, Iris S. Molina, Luis Barcena-Flores, Alicia Nuñez, Nieves Sevilla, Steve V. Acedo-Lazo, Estela Huamán-Angeles, Princesa Medrano, Kelly Izarra, Alexander Fajardo, Vanesa Dominguez, Karla Vasquez, Orson Mestanza, Francisco Ascue, Henri Bailon, Marco Galarza-Pérez, Omar Caceres-Rey, Roger V. Araujo‐Castillo, Natalia Vargas‐Herrera, Joseph Huayra, Gloria Arotinco-Garayar, Priscila Lope‐Pari, Johanna Balbuena-Torres, Nancy Rojas‐Serrano
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
